Search

Your search keyword '"John M. Flack"' showing total 268 results

Search Constraints

Start Over You searched for: Author "John M. Flack" Remove constraint Author: "John M. Flack"
268 results on '"John M. Flack"'

Search Results

51. Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease

52. Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

53. Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis

54. A Novel Approach for Estimating Cost-Effectiveness of Pharmacological Treatment in Drug Naïve Adults with Hypertension

55. Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction

56. Do We Need a New Definition of Hypertension After SPRINT?

57. A preliminary experimental examination of worldview verification, perceived racism, and stress reactivity in African Americans

58. Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis

59. Relationship of Resistant Hypertension and Treatment Outcomes With Total Arterial Compliance in a Predominantly African American Hypertensive Cohort

60. Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension

61. Vitamin D and Parathyroid Hormone Relationships with Urinary Nitric Oxide Metabolites and Plasma Isoprostanes in African-Americans

62. A Message From the New Editorial Team at the American Journal of Hypertension

63. Benefits of once-daily therapies in the treatment of hypertension

64. Alpha 1 Adrenoreceptor Antagonists

65. Prevalence, Determinants, and Clinical Significance of Cardiac Troponin-I Elevation in Individuals Admitted for a Hypertensive Emergency

66. Therapy of Hypertension in African Americans

67. Treatment of Heart Failure in African Americans— A Call to Action

68. A Randomized, Double-Blind, Forced-Titration Study to Compare Olmesartan Medoxomil versus Losartan Potassium in Patients with Stage 1 and 2 Hypertension

69. Management of High Blood Pressure in Blacks

70. Hypertension in Special Populations: Chronic Kidney Disease, Organ Transplant Recipients, Pregnancy, Autonomic Dysfunction, Racial and Ethnic Populations

71. 106 Estimation of Medication Adherence by Morisky Medication Adherence Scale-4 Construct Compared to Liquid Chromatography Mass Spectrometry in Emergency Department Patients With Chronic Hypertension

72. Treatment Considerations With Aldosterone Receptor Antagonists

73. Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans

74. Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary Study

75. Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health Disparities

76. The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants

77. Underuse of antihypertensive therapies in at-risk populations

78. Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial

79. Epidemiology and Unmet Needs in Hypertension

81. Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide

82. The Role of Therapeutic Inertia and the Use of Fixed-Dose Combination Therapy in the Management of Hypertension

83. Poor Nutrient Intake and High Obese Rate in an Urban African American Population with Hypertension

84. Genetic African Ancestry and Markers of Mineral Metabolism in CKD

85. As-needed intravenous antihypertensive therapy and blood pressure control

86. Depression, Stress, and Blood Pressure in Urban African‐American Women

87. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial

88. A Noninferiority Comparison of Valsartan/Hydrochlorothiazide Combination Versus Amlodipine in Black Hypertensives

89. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program

90. From 1960s Evans County Georgia to Present-Day Jackson, Mississippi: An Exploration of the Evolution of Cardiovascular Disease in African Americans

91. Primary Renal Disease as a Cardiovascular Risk Factor

92. Design of the omapatrilat in persons with enhanced risk of atherosclerotic events (OPERA) trial

93. Hypertension in African Americans

94. Utility of Framingham Risk Score in Urban Emergency Department Patients with Asymptomatic Hypertension

95. Differences and Similarities in Explanatory Models of Hypertension in the United States of America, Tanzania and Jamaica

96. Primary Care in the Emergency Department – An Untapped Resource for Public Health Research and Innovation

97. Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension

98. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension

99. The Accumulative Effects of Physical Activity in Hypertensive Post-Menopausal Women

100. Should African Americans with hypertension be treated differently than non-African Americans?

Catalog

Books, media, physical & digital resources